metered dose aerosol inhaler
Why is it prescribed?
Alvesco® MDI contains ciclesonide.
Ciclesonide is used to control the signs and symptoms of asthma that are responsive to orally inhaled corticosteroids in patients over 6 years of age. Ciclesonide is not presently recommended for those less than 6 years of age. It is also used as a nasal spray to relieve the symptoms that may occur with hay fever [seasonal allergic rhinitis (SAR)] or other year-round allergies [perennial allergic rhinitis (PAR)], including stuffiness/congestion in the nose, runny nose, itching and sneezing.
Alvesco® MDI contains ciclesonide.
Along with its needed effects, ciclesonide may cause some unwanted or undesirable effects. Often, ciclesonide users who use their medication properly, never experience any unwanted effects. The severity and duration of these effects are dependant on many factors including duration of therapy, dose, route of administration and individual response. Possible unwanted effects include:
When used as a nasal spray, headache, nose-bleeds, and burning or irritation inside the nose can occur.
Precautions and Warnings for Alvesco® MDI
Alvesco® MDI contains ciclesonide
Use as directed. Never use a higher dose than what you have been prescribed. Using higher than recommended doses will cause greater absorption by the body and possibly lead to greater occurrence of unwanted effects. Optimal relief of symptoms may require a few days of continuous therapy.
If symptoms do not improve or the condition worsens, the doctor should be contacted.
Treatment with ciclesonide should never be stopped without first consulting your doctor.
Discontinuation of ciclesonide may require gradual tapering or you may experience a flare-up of your condition.
Inadequate response can often be a result of improper use of the delivery device. Your doctor or pharmacist should instruct you on the correct use of these preparations. Each product comes with a package insert that should be read and then kept as a reference.
It is important to inform subsequent physicians that you are using or have used ciclesonide or any other corticosteroids as this may vary the treatment plan.
When you have been treated with oral corticosteroids (e.g. prednisone) for prolonged periods and are being transferred to orally inhaled ciclesonide, you may experience withdrawal symptoms (e.g. joint and/or muscular pain and depression). These symptoms should be reported to your doctor, especially if you have associated asthma or another condition in which too rapid a decrease in systemic steroids may cause a severe flare-up of symptoms. Ciclesonide may mask some signs of infection and new infections may appear. The body tends to have a decreased resistance to localized infections while on this therapy so anything of this nature should be reported to the doctor.
Caution is recommended in the following situations:
Use in pregnancy:
Consult your doctor if you suspect you are pregnant or if you are breastfeeding. Ciclesonide should only be used in pregnancy or while breast feeding if the benefit to the mother outweighs the risk to the fetus or baby.
Alvesco® is an aerosol meant for inhalation by
mouth only. Your doctor or pharmacist should have
instructed you on the proper use and care of your
Alvesco® aerosol. It is advisable to have your
technique reassessed by the pharmacist for the
first 2 or 3 refills of your prescription.
Directions for Use
For adults and adolescents (age over 12 years) the
usual dose for ciclesonide ranges from 100 to 800
micrograms per day. Ciclesonide can be taken as 1
or 2 puffs once daily either in the morning or in
the evening. Some patients with more severe
asthma will require 800 micrograms daily,
administered as 400 micrograms twice daily.
Lung Diseases Treated with this Drug
Need More Information?
For more information contact your physician, pharmacist, other health care professional or for general questions call your local lung association.